176 related articles for article (PubMed ID: 29672841)
21. Is Familial Nonmedullary Thyroid Cancer A More Aggressive Type of Thyroid Cancer?
Muallem Kalmovich L; Jabarin B; Koren S; Or K; Marcus E; Tkacheva I; Benbassat C; Steinschneider M
Laryngoscope; 2021 Feb; 131(2):E677-E681. PubMed ID: 32761812
[TBL] [Abstract][Full Text] [Related]
22. Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity.
Capezzone M; Marchisotta S; Cantara S; Busonero G; Brilli L; Pazaitou-Panayiotou K; Carli AF; Caruso G; Toti P; Capitani S; Pammolli A; Pacini F
Endocr Relat Cancer; 2008 Dec; 15(4):1075-81. PubMed ID: 18832444
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic features of familial nonmedullary thyroid carcinoma.
Fan YF; Zhang B; Yang X; Shang ZH; Liu HF; Xie Y; Liu YW; Gao WS; Wu Q; Li XY
Chin Med J (Engl); 2015 Apr; 128(8):1037-41. PubMed ID: 25881596
[TBL] [Abstract][Full Text] [Related]
24. Whole Genome Sequencing Prioritizes
Srivastava A; Giangiobbe S; Skopelitou D; Miao B; Paramasivam N; Diquigiovanni C; Bonora E; Hemminki K; Försti A; Bandapalli OR
Front Endocrinol (Lausanne); 2021; 12():600682. PubMed ID: 33692755
[TBL] [Abstract][Full Text] [Related]
25. MYO1F as a candidate gene for nonsyndromic deafness, DFNB15.
Chen AH; Stephan DA; Hasson T; Fukushima K; Nelissen CM; Chen AF; Jun AI; Ramesh A; Van Camp G; Smith RJ
Arch Otolaryngol Head Neck Surg; 2001 Aug; 127(8):921-5. PubMed ID: 11493199
[TBL] [Abstract][Full Text] [Related]
26. Germline Heterozygous Variants in SEC23B Are Associated with Cowden Syndrome and Enriched in Apparently Sporadic Thyroid Cancer.
Yehia L; Niazi F; Ni Y; Ngeow J; Sankunny M; Liu Z; Wei W; Mester JL; Keri RA; Zhang B; Eng C
Am J Hum Genet; 2015 Nov; 97(5):661-76. PubMed ID: 26522472
[TBL] [Abstract][Full Text] [Related]
27. Familial nonmedullary thyroid carcinoma.
Mazeh H; Sippel RS
Thyroid; 2013 Sep; 23(9):1049-56. PubMed ID: 23734600
[TBL] [Abstract][Full Text] [Related]
28. Segregation and expression analyses of hyaluronan-binding protein 2 (HABP2): insights from a large series of familial non-medullary thyroid cancers and literature review.
Colombo C; Muzza M; Proverbio MC; Ercoli G; Perrino M; Cirello V; Vicentini L; Ferrero S; Fugazzola L
Clin Endocrinol (Oxf); 2017 Jun; 86(6):837-844. PubMed ID: 28222214
[TBL] [Abstract][Full Text] [Related]
29. [Next generation sequencing technology for susceptible gene screening in familial non-medullary thyroid carcinoma].
Dong L; Yu Y; Yu JP; Hao WJ; Zheng XQ; Cheng YN; Han L; Zhao JZ; Gao M
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):24-28. PubMed ID: 28104029
[No Abstract] [Full Text] [Related]
30. Mapping a new familial thyroid epithelial neoplasia susceptibility locus to chromosome 8p23.1-p22 by high-density single-nucleotide polymorphism genome-wide linkage analysis.
Cavaco BM; Batista PF; Sobrinho LG; Leite V
J Clin Endocrinol Metab; 2008 Nov; 93(11):4426-30. PubMed ID: 18765515
[TBL] [Abstract][Full Text] [Related]
31. Allelic loss of susceptibility loci and the occurrence of BRAF and RAS mutations in patients with familial non-medullary thyroid cancer.
Na KY; Kim RM; Song EM; Lee JH; Lee J; Soh EY
J Surg Oncol; 2012 Jan; 105(1):10-4. PubMed ID: 21826673
[TBL] [Abstract][Full Text] [Related]
32. Investigating
Teixeira E; Fernandes C; Bungărdean M; Paula ADC; Lima RT; Batista R; Vinagre J; Sobrinho-Simões M; Máximo V; Soares P
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338801
[TBL] [Abstract][Full Text] [Related]
33. In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease.
Mazeh H; Benavidez J; Poehls JL; Youngwirth L; Chen H; Sippel RS
Thyroid; 2012 Jan; 22(1):3-8. PubMed ID: 22136209
[TBL] [Abstract][Full Text] [Related]
34. Familial Aggregation and Heritability of Nonmedullary Thyroid Cancer in an Asian Population: A Nationwide Cohort Study.
Lin HT; Liu FC; Lin SF; Kuo CF; Chen YY; Yu HP
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32333767
[TBL] [Abstract][Full Text] [Related]
35. Clinical features of pediatric familial non-medullary thyroid cancer (FNMTC).
Capezzone M; Maino F; Sagnella A; Campanile M; Dalmiglio C; Pilli T; Forleo R; Castagna MG
J Endocrinol Invest; 2021 Oct; 44(10):2319-2321. PubMed ID: 33580435
[No Abstract] [Full Text] [Related]
36. A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci.
Tsilchorozidou T; Vafiadou E; Yovos JG; Romeo G; McKay J; Lesueur F; Bonora E
Thyroid; 2005 Dec; 15(12):1349-54. PubMed ID: 16405407
[TBL] [Abstract][Full Text] [Related]
37. Targeted DNA Sequencing Detects Mutations Related to Susceptibility among Familial Non-medullary Thyroid Cancer.
Yu Y; Dong L; Li D; Chuai S; Wu Z; Zheng X; Cheng Y; Han L; Yu J; Gao M
Sci Rep; 2015 Nov; 5():16129. PubMed ID: 26530882
[TBL] [Abstract][Full Text] [Related]
38. C14orf93 (RTFC) is identified as a novel susceptibility gene for familial nonmedullary thyroid cancer.
Liu C; Yu Y; Yin G; Zhang J; Wen W; Ruan X; Li D; Zhang S; Cai W; Gao M; Chen L
Biochem Biophys Res Commun; 2017 Jan; 482(4):590-596. PubMed ID: 27864143
[TBL] [Abstract][Full Text] [Related]
39. Cribriform-Morular Variant of Papillary Thyroid Carcinoma With Poorly Differentiated Features: A Case Report With Immunohistochemical and Molecular Genetic Analysis.
Corean J; Furtado LV; Kadri S; Segal JP; Emerson LL
Int J Surg Pathol; 2019 May; 27(3):294-304. PubMed ID: 30176755
[TBL] [Abstract][Full Text] [Related]
40. HABP2 germline variants are uncommon in familial nonmedullary thyroid cancer.
Weeks AL; Wilson SG; Ward L; Goldblatt J; Hui J; Walsh JP
BMC Med Genet; 2016 Aug; 17(1):60. PubMed ID: 27530615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
